ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
STAT1
|
ENSG00000115415.14 | STAT1 |
STAT3
|
ENSG00000168610.10 | STAT3 |
BCL6
|
ENSG00000113916.13 | BCL6 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
STAT1 | hg19_v2_chr2_-_191885686_191885750 | -0.68 | 3.9e-03 | Click! |
STAT3 | hg19_v2_chr17_-_40540484_40540537 | -0.44 | 9.1e-02 | Click! |
BCL6 | hg19_v2_chr3_-_187454281_187454357 | 0.22 | 4.2e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_-_102668879 | 8.42 |
ENST00000315274.6 |
MMP1 |
matrix metallopeptidase 1 (interstitial collagenase) |
chr8_-_27469196 | 7.30 |
ENST00000546343.1 ENST00000560566.1 |
CLU |
clusterin |
chr7_+_134464414 | 7.11 |
ENST00000361901.2 |
CALD1 |
caldesmon 1 |
chr1_-_68299130 | 6.87 |
ENST00000370982.3 |
GNG12 |
guanine nucleotide binding protein (G protein), gamma 12 |
chr3_-_93692781 | 6.34 |
ENST00000394236.3 |
PROS1 |
protein S (alpha) |
chr17_+_32582293 | 6.25 |
ENST00000580907.1 ENST00000225831.4 |
CCL2 |
chemokine (C-C motif) ligand 2 |
chr9_-_117880477 | 6.13 |
ENST00000534839.1 ENST00000340094.3 ENST00000535648.1 ENST00000346706.3 ENST00000345230.3 ENST00000350763.4 |
TNC |
tenascin C |
chr8_-_27468842 | 6.08 |
ENST00000523500.1 |
CLU |
clusterin |
chr7_+_134464376 | 5.68 |
ENST00000454108.1 ENST00000361675.2 |
CALD1 |
caldesmon 1 |
chr8_-_27468945 | 5.38 |
ENST00000405140.3 |
CLU |
clusterin |
chr2_-_190044480 | 5.21 |
ENST00000374866.3 |
COL5A2 |
collagen, type V, alpha 2 |
chr3_-_149095652 | 4.74 |
ENST00000305366.3 |
TM4SF1 |
transmembrane 4 L six family member 1 |
chr14_-_30396948 | 4.42 |
ENST00000331968.5 |
PRKD1 |
protein kinase D1 |
chr10_-_33625154 | 3.48 |
ENST00000265371.4 |
NRP1 |
neuropilin 1 |
chr12_+_53443963 | 3.27 |
ENST00000546602.1 ENST00000552570.1 ENST00000549700.1 |
TENC1 |
tensin like C1 domain containing phosphatase (tensin 2) |
chrX_-_48931648 | 3.14 |
ENST00000376386.3 ENST00000376390.4 |
PRAF2 |
PRA1 domain family, member 2 |
chr12_-_91539918 | 3.09 |
ENST00000548218.1 |
DCN |
decorin |
chr15_-_60690932 | 3.06 |
ENST00000559818.1 |
ANXA2 |
annexin A2 |
chr12_+_53443680 | 3.05 |
ENST00000314250.6 ENST00000451358.1 |
TENC1 |
tensin like C1 domain containing phosphatase (tensin 2) |
chrX_-_10544942 | 3.02 |
ENST00000380779.1 |
MID1 |
midline 1 (Opitz/BBB syndrome) |
chr2_-_106013400 | 2.77 |
ENST00000409807.1 |
FHL2 |
four and a half LIM domains 2 |
chr1_+_163038565 | 2.67 |
ENST00000421743.2 |
RGS4 |
regulator of G-protein signaling 4 |
chr9_-_117853297 | 2.52 |
ENST00000542877.1 ENST00000537320.1 ENST00000341037.4 |
TNC |
tenascin C |
chr11_+_844067 | 2.50 |
ENST00000397406.1 ENST00000409543.2 ENST00000525201.1 |
TSPAN4 |
tetraspanin 4 |
chr10_-_90751038 | 2.48 |
ENST00000458159.1 ENST00000415557.1 ENST00000458208.1 |
ACTA2 |
actin, alpha 2, smooth muscle, aorta |
chr16_-_10652993 | 2.44 |
ENST00000536829.1 |
EMP2 |
epithelial membrane protein 2 |
chr1_+_163039143 | 2.42 |
ENST00000531057.1 ENST00000527809.1 ENST00000367908.4 |
RGS4 |
regulator of G-protein signaling 4 |
chr6_+_151561085 | 2.34 |
ENST00000402676.2 |
AKAP12 |
A kinase (PRKA) anchor protein 12 |
chr1_-_150780757 | 2.29 |
ENST00000271651.3 |
CTSK |
cathepsin K |
chr3_-_123512688 | 2.27 |
ENST00000475616.1 |
MYLK |
myosin light chain kinase |
chr15_+_63340647 | 2.25 |
ENST00000404484.4 |
TPM1 |
tropomyosin 1 (alpha) |
chr12_+_93964746 | 2.16 |
ENST00000536696.2 |
SOCS2 |
suppressor of cytokine signaling 2 |
chr19_+_15218180 | 2.09 |
ENST00000342784.2 ENST00000597977.1 ENST00000600440.1 |
SYDE1 |
synapse defective 1, Rho GTPase, homolog 1 (C. elegans) |
chr5_-_146781153 | 2.00 |
ENST00000520473.1 |
DPYSL3 |
dihydropyrimidinase-like 3 |
chr11_+_123986069 | 1.99 |
ENST00000456829.2 ENST00000361352.5 ENST00000449321.1 ENST00000392748.1 ENST00000360334.4 ENST00000392744.4 |
VWA5A |
von Willebrand factor A domain containing 5A |
chr12_+_102271129 | 1.99 |
ENST00000258534.8 |
DRAM1 |
DNA-damage regulated autophagy modulator 1 |
chr5_-_42812143 | 1.89 |
ENST00000514985.1 |
SEPP1 |
selenoprotein P, plasma, 1 |
chr9_-_75567962 | 1.81 |
ENST00000297785.3 ENST00000376939.1 |
ALDH1A1 |
aldehyde dehydrogenase 1 family, member A1 |
chr8_+_30300119 | 1.77 |
ENST00000520191.1 |
RBPMS |
RNA binding protein with multiple splicing |
chr1_-_154946825 | 1.76 |
ENST00000368453.4 ENST00000368450.1 ENST00000366442.2 |
SHC1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
chr15_+_63340734 | 1.64 |
ENST00000560959.1 |
TPM1 |
tropomyosin 1 (alpha) |
chr1_-_230850043 | 1.63 |
ENST00000366667.4 |
AGT |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
chr3_+_45067659 | 1.62 |
ENST00000296130.4 |
CLEC3B |
C-type lectin domain family 3, member B |
chr3_+_62304712 | 1.62 |
ENST00000494481.1 |
C3orf14 |
chromosome 3 open reading frame 14 |
chr8_-_18666360 | 1.59 |
ENST00000286485.8 |
PSD3 |
pleckstrin and Sec7 domain containing 3 |
chr17_-_1619535 | 1.58 |
ENST00000573075.1 ENST00000574306.1 |
MIR22HG |
MIR22 host gene (non-protein coding) |
chr5_-_111092873 | 1.57 |
ENST00000509025.1 ENST00000515855.1 |
NREP |
neuronal regeneration related protein |
chr3_+_62304648 | 1.54 |
ENST00000462069.1 ENST00000232519.5 ENST00000465142.1 |
C3orf14 |
chromosome 3 open reading frame 14 |
chr8_-_11710979 | 1.54 |
ENST00000415599.2 |
CTSB |
cathepsin B |
chr2_-_128399706 | 1.52 |
ENST00000426981.1 |
LIMS2 |
LIM and senescent cell antigen-like domains 2 |
chr5_-_122372354 | 1.52 |
ENST00000306442.4 |
PPIC |
peptidylprolyl isomerase C (cyclophilin C) |
chr3_-_185538849 | 1.52 |
ENST00000421047.2 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
chr12_-_133050726 | 1.45 |
ENST00000595994.1 |
MUC8 |
mucin 8 |
chr17_-_1619491 | 1.44 |
ENST00000570416.1 ENST00000575626.1 ENST00000610106.1 ENST00000608198.1 ENST00000609442.1 ENST00000334146.3 ENST00000576489.1 ENST00000608245.1 ENST00000609398.1 ENST00000608913.1 ENST00000574016.1 ENST00000571091.1 ENST00000573127.1 ENST00000609990.1 ENST00000576749.1 |
MIR22HG |
MIR22 host gene (non-protein coding) |
chr1_-_144994909 | 1.42 |
ENST00000369347.4 ENST00000369354.3 |
PDE4DIP |
phosphodiesterase 4D interacting protein |
chr6_-_52859046 | 1.41 |
ENST00000457564.1 ENST00000541324.1 ENST00000370960.1 |
GSTA4 |
glutathione S-transferase alpha 4 |
chr15_+_63340775 | 1.39 |
ENST00000559281.1 ENST00000317516.7 |
TPM1 |
tropomyosin 1 (alpha) |
chr12_-_7261772 | 1.36 |
ENST00000545280.1 ENST00000543933.1 ENST00000545337.1 ENST00000544702.1 ENST00000266542.4 |
C1RL |
complement component 1, r subcomponent-like |
chr1_+_221051699 | 1.36 |
ENST00000366903.6 |
HLX |
H2.0-like homeobox |
chr22_+_33197683 | 1.35 |
ENST00000266085.6 |
TIMP3 |
TIMP metallopeptidase inhibitor 3 |
chr2_-_167232484 | 1.35 |
ENST00000375387.4 ENST00000303354.6 ENST00000409672.1 |
SCN9A |
sodium channel, voltage-gated, type IX, alpha subunit |
chr1_-_144995002 | 1.34 |
ENST00000369356.4 |
PDE4DIP |
phosphodiesterase 4D interacting protein |
chr11_+_844406 | 1.33 |
ENST00000397404.1 |
TSPAN4 |
tetraspanin 4 |
chr4_+_169418195 | 1.31 |
ENST00000261509.6 ENST00000335742.7 |
PALLD |
palladin, cytoskeletal associated protein |
chr3_+_136537911 | 1.30 |
ENST00000393079.3 |
SLC35G2 |
solute carrier family 35, member G2 |
chr15_-_60690163 | 1.28 |
ENST00000558998.1 ENST00000560165.1 ENST00000557986.1 ENST00000559780.1 ENST00000559467.1 ENST00000559956.1 ENST00000332680.4 ENST00000396024.3 ENST00000421017.2 ENST00000560466.1 ENST00000558132.1 ENST00000559113.1 ENST00000557906.1 ENST00000558558.1 ENST00000560468.1 ENST00000559370.1 ENST00000558169.1 ENST00000559725.1 ENST00000558985.1 ENST00000451270.2 |
ANXA2 |
annexin A2 |
chr1_+_223900034 | 1.28 |
ENST00000295006.5 |
CAPN2 |
calpain 2, (m/II) large subunit |
chr1_-_31845914 | 1.26 |
ENST00000373713.2 |
FABP3 |
fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) |
chr14_-_92414055 | 1.26 |
ENST00000342058.4 |
FBLN5 |
fibulin 5 |
chr16_+_69221028 | 1.24 |
ENST00000336278.4 |
SNTB2 |
syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2) |
chr11_+_57365150 | 1.24 |
ENST00000457869.1 ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1 |
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
chr3_+_136537816 | 1.23 |
ENST00000446465.2 |
SLC35G2 |
solute carrier family 35, member G2 |
chr4_-_140005341 | 1.17 |
ENST00000379549.2 ENST00000512627.1 |
ELF2 |
E74-like factor 2 (ets domain transcription factor) |
chr5_-_121413974 | 1.17 |
ENST00000231004.4 |
LOX |
lysyl oxidase |
chr6_+_30130969 | 1.15 |
ENST00000376694.4 |
TRIM15 |
tripartite motif containing 15 |
chr12_-_56120838 | 1.15 |
ENST00000548160.1 |
CD63 |
CD63 molecule |
chr22_+_38609538 | 1.13 |
ENST00000407965.1 |
MAFF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
chr4_-_140005443 | 1.13 |
ENST00000510408.1 ENST00000420916.2 ENST00000358635.3 |
ELF2 |
E74-like factor 2 (ets domain transcription factor) |
chr12_-_120687948 | 1.11 |
ENST00000458477.2 |
PXN |
paxillin |
chr8_+_71485681 | 1.11 |
ENST00000391684.1 |
AC120194.1 |
AC120194.1 |
chr12_-_56120865 | 1.09 |
ENST00000548898.1 ENST00000552067.1 |
CD63 |
CD63 molecule |
chr1_-_94374946 | 1.09 |
ENST00000370238.3 |
GCLM |
glutamate-cysteine ligase, modifier subunit |
chr14_-_21270995 | 1.07 |
ENST00000555698.1 ENST00000397970.4 ENST00000340900.3 |
RNASE1 |
ribonuclease, RNase A family, 1 (pancreatic) |
chr1_+_154300217 | 1.07 |
ENST00000368489.3 |
ATP8B2 |
ATPase, aminophospholipid transporter, class I, type 8B, member 2 |
chr22_-_36357671 | 1.05 |
ENST00000408983.2 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chrX_+_102631248 | 1.03 |
ENST00000361298.4 ENST00000372645.3 ENST00000372635.1 |
NGFRAP1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr14_+_94577074 | 1.01 |
ENST00000444961.1 ENST00000448882.1 ENST00000557098.1 ENST00000554800.1 ENST00000556544.1 ENST00000298902.5 ENST00000555819.1 ENST00000557634.1 ENST00000555744.1 |
IFI27 |
interferon, alpha-inducible protein 27 |
chr17_-_76975925 | 1.00 |
ENST00000591274.1 ENST00000589906.1 ENST00000591778.1 ENST00000589775.2 ENST00000585407.1 ENST00000262776.3 |
LGALS3BP |
lectin, galactoside-binding, soluble, 3 binding protein |
chr1_-_144994840 | 1.00 |
ENST00000369351.3 ENST00000369349.3 |
PDE4DIP |
phosphodiesterase 4D interacting protein |
chr14_+_22458631 | 0.99 |
ENST00000390444.1 |
TRAV16 |
T cell receptor alpha variable 16 |
chr17_+_6347729 | 0.98 |
ENST00000572447.1 |
FAM64A |
family with sequence similarity 64, member A |
chr3_+_46283916 | 0.98 |
ENST00000395940.2 |
CCR3 |
chemokine (C-C motif) receptor 3 |
chr1_-_203155868 | 0.98 |
ENST00000255409.3 |
CHI3L1 |
chitinase 3-like 1 (cartilage glycoprotein-39) |
chr5_-_111093081 | 0.97 |
ENST00000453526.2 ENST00000509427.1 |
NREP |
neuronal regeneration related protein |
chr1_-_201476274 | 0.96 |
ENST00000340006.2 |
CSRP1 |
cysteine and glycine-rich protein 1 |
chrX_+_106045891 | 0.95 |
ENST00000357242.5 ENST00000310452.2 ENST00000481617.2 ENST00000276175.3 |
TBC1D8B |
TBC1 domain family, member 8B (with GRAM domain) |
chr3_+_46283863 | 0.94 |
ENST00000545097.1 ENST00000541018.1 |
CCR3 |
chemokine (C-C motif) receptor 3 |
chr9_+_124088860 | 0.94 |
ENST00000373806.1 |
GSN |
gelsolin |
chr14_-_21270561 | 0.93 |
ENST00000412779.2 |
RNASE1 |
ribonuclease, RNase A family, 1 (pancreatic) |
chr5_-_111092930 | 0.92 |
ENST00000257435.7 |
NREP |
neuronal regeneration related protein |
chr4_+_166300084 | 0.91 |
ENST00000402744.4 |
CPE |
carboxypeptidase E |
chr9_-_89562104 | 0.90 |
ENST00000298743.7 |
GAS1 |
growth arrest-specific 1 |
chr19_-_40324255 | 0.89 |
ENST00000593685.1 ENST00000600611.1 |
DYRK1B |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B |
chr5_+_148521381 | 0.89 |
ENST00000504238.1 |
ABLIM3 |
actin binding LIM protein family, member 3 |
chr1_-_144995074 | 0.89 |
ENST00000534536.1 |
PDE4DIP |
phosphodiesterase 4D interacting protein |
chr17_+_35851570 | 0.88 |
ENST00000394386.1 |
DUSP14 |
dual specificity phosphatase 14 |
chr6_+_108977520 | 0.88 |
ENST00000540898.1 |
FOXO3 |
forkhead box O3 |
chr1_+_162602244 | 0.87 |
ENST00000367922.3 ENST00000367921.3 |
DDR2 |
discoidin domain receptor tyrosine kinase 2 |
chr4_+_126237554 | 0.86 |
ENST00000394329.3 |
FAT4 |
FAT atypical cadherin 4 |
chr8_-_120651020 | 0.86 |
ENST00000522826.1 ENST00000520066.1 ENST00000259486.6 ENST00000075322.6 |
ENPP2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
chr4_+_86396265 | 0.86 |
ENST00000395184.1 |
ARHGAP24 |
Rho GTPase activating protein 24 |
chr22_+_38597889 | 0.84 |
ENST00000338483.2 ENST00000538320.1 ENST00000538999.1 ENST00000441709.1 |
MAFF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
chr17_-_1359443 | 0.82 |
ENST00000574295.1 ENST00000398970.5 ENST00000300574.2 |
CRK |
v-crk avian sarcoma virus CT10 oncogene homolog |
chr17_+_6347761 | 0.82 |
ENST00000250056.8 ENST00000571373.1 ENST00000570337.2 ENST00000572595.2 ENST00000576056.1 |
FAM64A |
family with sequence similarity 64, member A |
chr5_-_111093167 | 0.82 |
ENST00000446294.2 ENST00000419114.2 |
NREP |
neuronal regeneration related protein |
chr11_+_46740730 | 0.82 |
ENST00000311907.5 ENST00000530231.1 ENST00000442468.1 |
F2 |
coagulation factor II (thrombin) |
chr22_-_27620603 | 0.81 |
ENST00000418271.1 ENST00000444114.1 |
RP5-1172A22.1 |
RP5-1172A22.1 |
chr6_-_131321863 | 0.80 |
ENST00000528282.1 |
EPB41L2 |
erythrocyte membrane protein band 4.1-like 2 |
chr4_+_41258786 | 0.78 |
ENST00000503431.1 ENST00000284440.4 ENST00000508768.1 ENST00000512788.1 |
UCHL1 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
chr7_+_128399002 | 0.77 |
ENST00000493278.1 |
CALU |
calumenin |
chr5_-_111093406 | 0.75 |
ENST00000379671.3 |
NREP |
neuronal regeneration related protein |
chr4_+_169418255 | 0.75 |
ENST00000505667.1 ENST00000511948.1 |
PALLD |
palladin, cytoskeletal associated protein |
chr11_-_111782696 | 0.74 |
ENST00000227251.3 ENST00000526180.1 |
CRYAB |
crystallin, alpha B |
chr2_+_17935119 | 0.74 |
ENST00000317402.7 |
GEN1 |
GEN1 Holliday junction 5' flap endonuclease |
chr7_+_98923505 | 0.74 |
ENST00000432884.2 ENST00000262942.5 |
ARPC1A |
actin related protein 2/3 complex, subunit 1A, 41kDa |
chr1_+_207262881 | 0.74 |
ENST00000451804.2 |
C4BPB |
complement component 4 binding protein, beta |
chr12_-_56121580 | 0.73 |
ENST00000550776.1 |
CD63 |
CD63 molecule |
chr4_-_110723134 | 0.73 |
ENST00000510800.1 ENST00000512148.1 |
CFI |
complement factor I |
chr12_-_56121612 | 0.73 |
ENST00000546939.1 |
CD63 |
CD63 molecule |
chr4_+_8594477 | 0.73 |
ENST00000315782.6 |
CPZ |
carboxypeptidase Z |
chr1_+_207262578 | 0.71 |
ENST00000243611.5 ENST00000367076.3 |
C4BPB |
complement component 4 binding protein, beta |
chr5_-_111093340 | 0.71 |
ENST00000508870.1 |
NREP |
neuronal regeneration related protein |
chr6_-_46889694 | 0.71 |
ENST00000283296.7 ENST00000362015.4 ENST00000456426.2 |
GPR116 |
G protein-coupled receptor 116 |
chr3_+_135741576 | 0.71 |
ENST00000334546.2 |
PPP2R3A |
protein phosphatase 2, regulatory subunit B'', alpha |
chr1_+_207262627 | 0.70 |
ENST00000391923.1 |
C4BPB |
complement component 4 binding protein, beta |
chr1_+_155099927 | 0.70 |
ENST00000368407.3 |
EFNA1 |
ephrin-A1 |
chr1_+_17906970 | 0.70 |
ENST00000375415.1 |
ARHGEF10L |
Rho guanine nucleotide exchange factor (GEF) 10-like |
chr20_+_44036900 | 0.68 |
ENST00000443296.1 |
DBNDD2 |
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
chr4_-_110723335 | 0.67 |
ENST00000394634.2 |
CFI |
complement factor I |
chr2_-_183291741 | 0.67 |
ENST00000351439.5 ENST00000409365.1 |
PDE1A |
phosphodiesterase 1A, calmodulin-dependent |
chr5_-_179499108 | 0.66 |
ENST00000521389.1 |
RNF130 |
ring finger protein 130 |
chr2_+_17935383 | 0.66 |
ENST00000524465.1 ENST00000381254.2 ENST00000532257.1 |
GEN1 |
GEN1 Holliday junction 5' flap endonuclease |
chr4_-_110723194 | 0.66 |
ENST00000394635.3 |
CFI |
complement factor I |
chr4_-_155533787 | 0.66 |
ENST00000407946.1 ENST00000405164.1 ENST00000336098.3 ENST00000393846.2 ENST00000404648.3 ENST00000443553.1 |
FGG |
fibrinogen gamma chain |
chrY_+_16634483 | 0.66 |
ENST00000382872.1 |
NLGN4Y |
neuroligin 4, Y-linked |
chr16_-_89785777 | 0.64 |
ENST00000561976.1 |
VPS9D1 |
VPS9 domain containing 1 |
chr3_-_148939835 | 0.64 |
ENST00000264613.6 |
CP |
ceruloplasmin (ferroxidase) |
chr17_+_48624450 | 0.63 |
ENST00000006658.6 ENST00000356488.4 ENST00000393244.3 |
SPATA20 |
spermatogenesis associated 20 |
chr1_+_6845384 | 0.62 |
ENST00000303635.7 |
CAMTA1 |
calmodulin binding transcription activator 1 |
chr7_+_76026832 | 0.62 |
ENST00000336517.4 |
ZP3 |
zona pellucida glycoprotein 3 (sperm receptor) |
chr6_-_43484718 | 0.61 |
ENST00000372422.2 |
YIPF3 |
Yip1 domain family, member 3 |
chr7_-_74267836 | 0.61 |
ENST00000361071.5 ENST00000453619.2 ENST00000417115.2 ENST00000405086.2 |
GTF2IRD2 |
GTF2I repeat domain containing 2 |
chr1_-_8000872 | 0.60 |
ENST00000377507.3 |
TNFRSF9 |
tumor necrosis factor receptor superfamily, member 9 |
chrX_+_129473916 | 0.60 |
ENST00000545805.1 ENST00000543953.1 ENST00000218197.5 |
SLC25A14 |
solute carrier family 25 (mitochondrial carrier, brain), member 14 |
chr1_+_207262540 | 0.59 |
ENST00000452902.2 |
C4BPB |
complement component 4 binding protein, beta |
chrX_-_102941596 | 0.59 |
ENST00000441076.2 ENST00000422355.1 ENST00000442614.1 ENST00000422154.2 ENST00000451301.1 |
MORF4L2 |
mortality factor 4 like 2 |
chr6_-_83903600 | 0.59 |
ENST00000506587.1 ENST00000507554.1 |
PGM3 |
phosphoglucomutase 3 |
chr1_+_84609944 | 0.58 |
ENST00000370685.3 |
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
chr5_-_132113083 | 0.58 |
ENST00000296873.7 |
SEPT8 |
septin 8 |
chr5_-_140013275 | 0.58 |
ENST00000512545.1 ENST00000302014.6 ENST00000401743.2 |
CD14 |
CD14 molecule |
chr1_-_173020056 | 0.57 |
ENST00000239468.2 ENST00000404377.3 |
TNFSF18 |
tumor necrosis factor (ligand) superfamily, member 18 |
chr3_-_114866084 | 0.57 |
ENST00000357258.3 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
chr2_+_242255297 | 0.57 |
ENST00000401990.1 ENST00000407971.1 ENST00000436795.1 ENST00000411484.1 ENST00000434955.1 ENST00000402092.2 ENST00000441533.1 ENST00000443492.1 ENST00000437066.1 ENST00000429791.1 |
SEPT2 |
septin 2 |
chr5_-_132113036 | 0.56 |
ENST00000378706.1 |
SEPT8 |
septin 8 |
chr17_+_77021702 | 0.56 |
ENST00000392445.2 ENST00000354124.3 |
C1QTNF1 |
C1q and tumor necrosis factor related protein 1 |
chr3_+_183894566 | 0.55 |
ENST00000439647.1 |
AP2M1 |
adaptor-related protein complex 2, mu 1 subunit |
chr6_-_122792919 | 0.54 |
ENST00000339697.4 |
SERINC1 |
serine incorporator 1 |
chr7_-_38671098 | 0.54 |
ENST00000356264.2 |
AMPH |
amphiphysin |
chr5_-_132112907 | 0.54 |
ENST00000458488.2 |
SEPT8 |
septin 8 |
chr5_-_132112921 | 0.53 |
ENST00000378721.4 ENST00000378701.1 |
SEPT8 |
septin 8 |
chr6_-_43484621 | 0.53 |
ENST00000506469.1 ENST00000503972.1 |
YIPF3 |
Yip1 domain family, member 3 |
chr12_+_13197218 | 0.53 |
ENST00000197268.8 |
KIAA1467 |
KIAA1467 |
chr22_+_20748405 | 0.52 |
ENST00000400451.2 ENST00000403682.3 ENST00000357502.5 |
ZNF74 |
zinc finger protein 74 |
chr7_+_74508372 | 0.52 |
ENST00000356115.5 ENST00000430511.2 ENST00000312575.7 |
GTF2IRD2B |
GTF2I repeat domain containing 2B |
chr14_+_62229075 | 0.51 |
ENST00000216294.4 |
SNAPC1 |
small nuclear RNA activating complex, polypeptide 1, 43kDa |
chr7_-_38670957 | 0.49 |
ENST00000325590.5 ENST00000428293.2 |
AMPH |
amphiphysin |
chr2_+_242254679 | 0.48 |
ENST00000428282.1 ENST00000360051.3 |
SEPT2 |
septin 2 |
chr11_-_111782484 | 0.48 |
ENST00000533971.1 |
CRYAB |
crystallin, alpha B |
chr1_+_207262170 | 0.48 |
ENST00000367078.3 |
C4BPB |
complement component 4 binding protein, beta |
chr8_-_6420930 | 0.48 |
ENST00000325203.5 |
ANGPT2 |
angiopoietin 2 |
chr7_-_108096765 | 0.48 |
ENST00000379024.4 ENST00000351718.4 |
NRCAM |
neuronal cell adhesion molecule |
chr15_+_58702742 | 0.48 |
ENST00000356113.6 ENST00000414170.3 |
LIPC |
lipase, hepatic |
chr15_-_56209306 | 0.47 |
ENST00000506154.1 ENST00000338963.2 ENST00000508342.1 |
NEDD4 |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
chr19_+_35168633 | 0.47 |
ENST00000505365.2 |
ZNF302 |
zinc finger protein 302 |
chr16_+_29471210 | 0.47 |
ENST00000360423.7 |
SULT1A4 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4 |
chr12_-_10007448 | 0.47 |
ENST00000538152.1 |
CLEC2B |
C-type lectin domain family 2, member B |
chr1_+_155290677 | 0.47 |
ENST00000368354.3 ENST00000368352.5 |
RUSC1 |
RUN and SH3 domain containing 1 |
chr14_+_45431379 | 0.46 |
ENST00000361577.3 ENST00000361462.2 ENST00000382233.2 |
FAM179B |
family with sequence similarity 179, member B |
chr12_+_56211703 | 0.46 |
ENST00000243045.5 ENST00000552672.1 ENST00000550836.1 |
ORMDL2 |
ORM1-like 2 (S. cerevisiae) |
chr10_+_93558069 | 0.45 |
ENST00000371627.4 |
TNKS2 |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2 |
chr6_+_3068606 | 0.45 |
ENST00000259808.4 |
RIPK1 |
receptor (TNFRSF)-interacting serine-threonine kinase 1 |
chr9_-_99145957 | 0.44 |
ENST00000375257.1 ENST00000253270.7 ENST00000375259.4 |
SLC35D2 |
solute carrier family 35 (UDP-GlcNAc/UDP-glucose transporter), member D2 |
chr12_-_88974236 | 0.44 |
ENST00000228280.5 ENST00000552044.1 ENST00000357116.4 |
KITLG |
KIT ligand |
chr8_-_6420777 | 0.44 |
ENST00000415216.1 |
ANGPT2 |
angiopoietin 2 |
chr14_-_25519095 | 0.43 |
ENST00000419632.2 ENST00000358326.2 ENST00000396700.1 ENST00000548724.1 |
STXBP6 |
syntaxin binding protein 6 (amisyn) |
chr19_-_45927622 | 0.43 |
ENST00000300853.3 ENST00000589165.1 |
ERCC1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
chr11_-_104817919 | 0.43 |
ENST00000533252.1 |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
chr12_-_10151773 | 0.43 |
ENST00000298527.6 ENST00000348658.4 |
CLEC1B |
C-type lectin domain family 1, member B |
chr11_-_62323702 | 0.42 |
ENST00000530285.1 |
AHNAK |
AHNAK nucleoprotein |
chr11_-_65363259 | 0.42 |
ENST00000342202.4 |
KCNK7 |
potassium channel, subfamily K, member 7 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.9 | 18.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.9 | 8.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.7 | 4.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.6 | 6.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.5 | 2.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 12.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.4 | 1.3 | GO:0070538 | oleic acid binding(GO:0070538) |
0.4 | 3.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.4 | 1.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.4 | 2.2 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.3 | 2.0 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.3 | 2.0 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.3 | 0.9 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.3 | 1.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.3 | 1.8 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.3 | 1.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.6 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.2 | 1.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 0.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 2.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 4.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 1.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.8 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 3.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 3.8 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 0.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 1.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 1.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 0.3 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 0.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 0.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.3 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.8 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 1.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.8 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 1.7 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 1.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.9 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.8 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
0.1 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.6 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 1.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 1.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.6 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 7.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.8 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 0.3 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.1 | 0.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 3.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 5.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.9 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.2 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 3.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.2 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.1 | 5.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.3 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.1 | 0.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 1.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 1.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 6.3 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 1.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.0 | 0.3 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.0 | 1.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 1.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 1.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 1.1 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.0 | 0.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.7 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.2 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.0 | 0.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.6 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.1 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.0 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 5.4 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.0 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 1.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.0 | 0.4 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.6 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.1 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.0 | 0.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.0 | 0.9 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 0.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.2 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.0 | 0.1 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.0 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.6 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0052658 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.2 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.2 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 3.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 18.8 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
2.9 | 8.6 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
2.1 | 6.2 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
1.4 | 4.3 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
1.3 | 5.2 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.7 | 3.5 | GO:1905040 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.7 | 5.3 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.6 | 4.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.6 | 1.8 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.6 | 2.8 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.5 | 1.6 | GO:0034226 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
0.5 | 2.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.5 | 1.5 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
0.5 | 1.4 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
0.5 | 2.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 7.2 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.4 | 1.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.4 | 2.5 | GO:0090131 | mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) mesenchyme migration(GO:0090131) |
0.4 | 7.7 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.4 | 1.1 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.4 | 3.2 | GO:1903027 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) regulation of opsonization(GO:1903027) |
0.3 | 1.3 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 8.5 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.3 | 1.2 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.3 | 0.9 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.3 | 0.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 2.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 0.8 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 3.1 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.2 | 0.5 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.2 | 3.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 1.6 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 1.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.2 | 1.1 | GO:0030070 | insulin processing(GO:0030070) |
0.2 | 0.6 | GO:2000360 | positive regulation of female gonad development(GO:2000196) negative regulation of binding of sperm to zona pellucida(GO:2000360) |
0.2 | 2.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.9 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.2 | 1.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 0.7 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.6 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.2 | 0.5 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.2 | 0.5 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.2 | 0.5 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.4 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.1 | 0.4 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.6 | GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 0.6 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.1 | 2.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.8 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.6 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 1.2 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 7.0 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.8 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 2.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 5.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.4 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.1 | 1.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.6 | GO:0006041 | glucosamine metabolic process(GO:0006041) glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 3.4 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.8 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.6 | GO:2001183 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
0.1 | 1.9 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.8 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.3 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 0.3 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.1 | 0.3 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 2.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 1.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.3 | GO:0090135 | B-1 B cell homeostasis(GO:0001922) actin filament branching(GO:0090135) |
0.1 | 1.7 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 1.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.8 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 1.8 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.4 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 1.6 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.9 | GO:0090091 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.4 | GO:2000784 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) regulation of barbed-end actin filament capping(GO:2000812) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.1 | 0.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 1.5 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.2 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.1 | 0.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 0.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.5 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
0.1 | 1.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 1.3 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.4 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 0.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.5 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.8 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 0.2 | GO:0060620 | regulation of cholesterol import(GO:0060620) negative regulation of cholesterol import(GO:0060621) regulation of sterol import(GO:2000909) negative regulation of sterol import(GO:2000910) |
0.1 | 0.9 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.3 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.1 | 1.4 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 0.2 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.1 | 0.7 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 0.2 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 0.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.5 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.1 | GO:1904647 | response to rotenone(GO:1904647) |
0.0 | 0.2 | GO:0007538 | primary sex determination(GO:0007538) |
0.0 | 1.1 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.3 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.0 | 0.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.0 | 0.1 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.0 | 0.2 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
0.0 | 0.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.0 | 1.4 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.1 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.0 | 0.2 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.0 | 1.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.3 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.0 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.5 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.0 | 0.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.1 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.0 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.3 | GO:0035799 | ureter maturation(GO:0035799) |
0.0 | 0.9 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.4 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 2.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.3 | GO:2001234 | negative regulation of apoptotic signaling pathway(GO:2001234) |
0.0 | 3.0 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.0 | 0.1 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 1.0 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 0.1 | GO:0039516 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.0 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.2 | GO:0099612 | protein localization to axon(GO:0099612) |
0.0 | 0.3 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 1.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.1 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.3 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.5 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.4 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.9 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.3 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.2 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 0.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.3 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.0 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.5 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.1 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.0 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.3 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.0 | 0.1 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.0 | 0.6 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.0 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.6 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 1.7 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.0 | 0.1 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.0 | 0.2 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.4 | GO:0042073 | intraciliary transport(GO:0042073) |
0.0 | 0.3 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.1 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.0 | 0.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.0 | 0.7 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.2 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.7 | GO:0061053 | somite development(GO:0061053) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 17.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 9.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 18.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 5.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 7.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 2.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 9.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 3.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 2.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 1.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 7.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 1.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 1.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 1.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 1.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 2.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.4 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.2 | 18.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.9 | 13.7 | GO:0030478 | actin cap(GO:0030478) |
0.9 | 4.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.8 | 8.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.6 | 2.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.6 | 1.8 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.5 | 3.8 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.3 | 3.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 1.6 | GO:0001652 | granular component(GO:0001652) |
0.3 | 5.3 | GO:0032059 | bleb(GO:0032059) |
0.3 | 3.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 3.1 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 0.6 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.2 | 2.4 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 1.9 | GO:0097227 | sperm annulus(GO:0097227) |
0.1 | 1.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 6.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.8 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 4.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.5 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 1.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.3 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
0.1 | 1.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 3.7 | GO:0031430 | M band(GO:0031430) |
0.1 | 8.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 1.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.4 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.1 | 0.8 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.3 | GO:0071062 | rough endoplasmic reticulum lumen(GO:0048237) alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.8 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.3 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.7 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.2 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.1 | 0.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 2.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 1.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 1.4 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.3 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.0 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.8 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.6 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 1.2 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 1.9 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.7 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 1.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.1 | GO:0031673 | H zone(GO:0031673) |
0.0 | 1.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 3.3 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 0.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 10.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 1.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 2.8 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 1.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.1 | GO:0016938 | kinesin I complex(GO:0016938) |
0.0 | 0.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 2.1 | GO:0005901 | caveola(GO:0005901) |
0.0 | 4.3 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.4 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.1 | GO:0000806 | Y chromosome(GO:0000806) |
0.0 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.6 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 1.6 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.1 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.0 | 1.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.5 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 1.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.2 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 0.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.5 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 0.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.8 | GO:0005811 | lipid particle(GO:0005811) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 8.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 23.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 8.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 6.8 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.3 | 4.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 1.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 5.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 5.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 5.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 24.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.5 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 4.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 2.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 3.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 3.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 5.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 7.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 2.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 1.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 4.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 1.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.9 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 1.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 1.5 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.0 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.0 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.9 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 1.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |